• 2022
    • Stultiens, J. M. G., Top, W. M. C., Kimenai, D. M., Lehert, P., Bekers, O., Stehouwer, C. D. A., Kooy, A., & Meex, S. J. R. (2022). Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial. Cardiovascular Diabetology, 21(1), Article 49. https://doi.org/10.1186/s12933-022-01482-z
    • Witten, A., Martens, L., Schäfer, A.-C., Troidl, C., Pankuweit, S., Vlacil, A.-K., Oberoi, R., Schieffer, B., Grote, K., Stoll, M., & Markus, B. (2022). Monocyte subpopulation profiling indicates CDK6-derived cell differentiation and identifies subpopulation-specific miRNA expression sets in acute and stable coronary artery disease. Scientific Reports, 12(1), Article 5589. https://doi.org/10.1038/s41598-022-08600-7
    • Denessen, E. J. S., Van den Kerkhof, D. L., Jeurissen, M. L. J., Wetzels, R. J. H., Verhezen, P. W. M., & Henskens, Y. M. C. (2022). Determining the Optimal Storage Time and Temperature for Performing Platelet Function Assays and Global Hemostasis Assays. Platelets, 33(3), 416-424. https://doi.org/10.1080/09537104.2021.1934666
    • van Lieshout, R., Lize, N., Tick, L. W., van Deursen, J., Driessen, E., Janssen, T., Custers, S., Kranenburg, S., van der Lee, D., Koene, H. R., Beckers, E. A. M., Schouten, H. C., & Beijer, S. (2022). Nutrition-related problems, nutritional support practices and barriers to adherence to nutritional guidelines during intensive treatment for acute myeloid leukemia: Patients' and hematology nurses' perspectives and experiences. Clinical Nutrition ESPEN, 48, 446-455. https://doi.org/10.1016/j.clnesp.2021.12.029
    • Cornelissen, L. L., Kreuger, A. L., Caram-Deelder, C., Huisman, M. V., Middelburg, R. A., Kerkhoffs, J. L. H., von dem Borne, P. A., Beckers, E. A. M., de Vooght, K. M. K., Kuball, J., van der Bom, J. G., & Zwaginga, J. J. (2022). Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia. European Journal of Haematology, 108(4), 310-318. https://doi.org/10.1111/ejh.13737
    • Mesotten, D., Meijs, D. A. M., van Bussel, B. C. T., Stessel, B., Mehagnoul-Schipper, J., Hana, A., Scheeren, C. I. E., Strauch, U., van de Poll, M. C. G., Ghossein-Doha, C., Buhre, W. F. F. A., Bickenbach, J., Vander Laenen, M., Marx, G., van der Horst, I. C. C., & COVID Data Platform (CoDaP) Investigators (2022). Differences and Similarities Among COVID-19 Patients Treated in Seven ICUs in Three Countries Within One Region: An Observational Cohort Study. Critical Care Medicine, 50(4), 595-606. https://doi.org/10.1097/CCM.0000000000005314
    • Mestrum, S. G. C., Cremers, E. M. P., de Wit, N. C. J., Drent, R. J. M., Ramaekers, F. C. S., Hopman, A. H. N., & Leers, M. P. G. (2022). Optimized gating strategy and supporting flow cytometry data for the determination of the Ki-67 proliferation index in the diagnosis of myelodysplastic syndrome. Data in brief, 41, Article 107976. https://doi.org/10.1016/j.dib.2022.107976
    • Karel, M. F. A., Tullemans, B. M. E., D'Italia, G., Lemmens, T. P., Claushuis, T. A. M., Kuijpers, M. J. E., & Cosemans, J. M. E. M. (2022). The effect of Bruton's tyrosine kinase inhibitor ibrutinib on atherothrombus formation under stenotic flow conditions. Thrombosis Research, 212, 72-80. https://doi.org/10.1016/j.thromres.2022.02.020
    • Dolleman, S. C., Agten, S. M., Spronk, H. M. H., Hackeng, T. M., Bos, M. H. A., Versteeg, H. H., van Zonneveld, A. J., & de Boer, H. C. (2022). Thrombin in complex with dabigatran can still interact with PAR-1 via exosite-I and instigate loss of vascular integrity. Journal of Thrombosis and Haemostasis, 20(4), 996-1007. https://doi.org/10.1111/jth.15642
    • Alaour, B., Omland, T., Torsvik, J., Kaier, T. E., Sylte, M. S., Strand, H., Quraishi, J., McGrath, S., Williams, L., Meex, S., Redwood, S., Marber, M., & Aakre, K. M. (2022). Biological variation of cardiac myosin-binding protein C in healthy individuals. Clinical Chemistry and Laboratory Medicine, 60(4), 576-583. https://doi.org/10.1515/cclm-2021-0306
    • Linschoten, M., Uijl, A., Schut, A., Jakob, C. E. M., Romao, L. R., Bell, R. M., McFarlane, E., Stecher, M., Zondag, A. G. M., van Iperen, E. P. A., Hermans-van Ast, J. F., Lea, N. C., Schaap, J., Jewbali, L. S., Smits, P. C., Patel, R. S., Aujayeb, A., van Smeden, M., Siebelink, H. J., ... Raafs, A. (2022). Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. European Heart Journal, 43(11), 1104-1120. https://doi.org/10.1093/eurheartj/ehab656
    • Hafeez, S., Ooi, H. W., Suylen, D., Duimel, H., Hackeng, T. M., van Blitterswijk, C., & Baker, M. B. (2022). Desymmetrization via Activated Esters Enables Rapid Synthesis of Multifunctional Benzene-1,3,5-tricarboxamides and Creation of Supramolecular Hydrogelators. Journal of the American Chemical Society, 144(9), 4057-4070. https://doi.org/10.1021/jacs.1c12685
    • Galli, M., Benenati, S., Franchi, F., Rollini, F., Capodanno, D., Biondi-Zoccai, G., Vescovo, G. M., Cavallari, L. H., Bikdeli, B., Ten Berg, J., Mehran, R., Gibson, C. M., Crea, F., Pereira, N. L., Sibbing, D., & Angiolillo, D. J. (2022). Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. European Heart Journal, 43(10), 959-967. https://doi.org/10.1093/eurheartj/ehab836
    • Henkens, M. T. H. M., Raafs, A. G., Verdonschot, J. A. J., Linschoten, M., van Smeden, M., Wang, P., van der Hooft, B. H. M., Tieleman, R., Janssen, M. L. F., Ter Bekke, R. M. A., Hazebroek, M. R., van der Horst, I. C. C., Asselbergs, F. W., Magdelijns, F. J. H., Heymans, S. R. B., & CAPACITY-COVID collaborative consortium (2022). Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study. BMC Geriatrics, 22(1), Article 184. https://doi.org/10.1186/s12877-021-02673-1
    • Poelman, H., Ippel, H., Gurkan, B., Boelens, R., Vriend, G., van 't Veer, C., Lutgens, E., & Nicolaes, G. A. F. (2022). Structural anomalies in a published NMR-derived structure of IRAK-M. Journal of Molecular Graphics & Modelling, 111, Article 108061. https://doi.org/10.1016/j.jmgm.2021.108061
    • Dauwerse, S., ten Cate, H., Spronk, H. M. H., & Nagy, M. (2022). The Composition and Physical Properties of Clots in COVID-19 Pathology. Diagnostics, 12(3), Article 580. https://doi.org/10.3390/diagnostics12030580
    • Herrera-Rivero, M., Gandhi, S., Witten, A., Ghalawinji, A., Schotten, U., & Stoll, M. (2022). Cardiac chamber-specific genetic alterations suggest candidate genes and pathways implicating the left ventricle in the pathogenesis of atrial fibrillation. Genomics, 114(2), Article 110320. https://doi.org/10.1016/j.ygeno.2022.110320
    • Claassens, D. M. F., van Dorst, P. W. M., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., Hof, A. W. J. V., van der Harst, P., Barbato, E., Morisco, C., Gin, R. M. T. J., Asselbergs, F. W., Mosterd, A., Herrman, J. P. R., Dewilde, W. J. M., Postma, M. J., Deneer, V. H. M., ten Berg, J. M., & Boersma, C. (2022). Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial. American Journal of Cardiovascular Drugs, 22(2), 195-206. https://doi.org/10.1007/s40256-021-00496-4
    • De Luca, G., Algowhary, M., Uguz, B., Oliveira, D. C., Ganyukov, V., Zimbakov, Z., Cercek, M., Jensen, L. O., Loh, P. H., Calmac, L., Roura-Ferrer, G., Quadros, A., Milewski, M., di Uccio, F. S., von Birgelen, C., Versaci, F., Ten Berg, J., Casella, G., Wong, A. S. L., ... Boccalatte, M. (2022). COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction. Heart, 108(6), 458-466. https://doi.org/10.1136/heartjnl-2021-319750
    • Grover, S. P., Coughlin, T., Fleifil, S. M., Posma, J. J. N., Spronk, H. H. M., Heitmeier, S., Owens, A. P., & Mackman, N. (2022). Effect of combining aspirin and rivaroxaban on atherosclerosis in mice. Atherosclerosis, 345, 7-14. https://doi.org/10.1016/j.atherosclerosis.2022.02.010
    • Simons, C. C. J. M., Offermans, N. S. M., Stoll, M., van den Brandt, P. A., & Weijenberg, M. P. (2022). Empirical Investigation of Genomic Clusters Associated with Height and the Risk of Postmenopausal Breast and Colorectal Cancer in the Netherlands Cohort Study. American Journal of Epidemiology, 191(3), 413-429. https://doi.org/10.1093/aje/kwab259
    • van der Sangen, N. M. R., Azzahhafi, J., Chan Pin Yin, D. R. P. P., Peper, J., Rayhi, S., Walhout, R. J., Tjon Joe Gin, M., Nicastia, D. M., Langerveld, J., Vlachojannis, G. J., van Bommel, R. J., Appelman, Y., Henriques, J. P. S., Ten Berg, J. M., & Kikkert, W. J. (2022). External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome. Open Heart, 9(1), Article e001984. https://doi.org/10.1136/openhrt-2022-001984
    • Heubel-Moenen, F. C. J. I., Brouns, S. L. N., Herfs, L., Boerenkamp, L. S., Jooss, N. J., Wetzels, R. J. H., Verhezen, P. W. M., Machiels, P., Megy, K., Downes, K., Heemskerk, J. W. M., Beckers, E. A. M., & Henskens, Y. M. C. (2022). Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time. British Journal of Haematology, 196(6), 1388-1400. https://doi.org/10.1111/bjh.18003
    • Panova-Noeva, M., Wagner, B., Nagler, M., Koeck, T., Ten Cate, V., Eggebrecht, L., Prochaska, J. H., Meyer, I., Gerdes, C., Spronk, H. M., Lackner, K. J., Ten Cate, H., Leineweber, K., Heitmeier, S., Konstantinides, S., & Wild, P. S. (2022). Variation of platelet function in clinical phenotypes of acute venous thromboembolism - Results from the GMP-VTE project. Journal of Thrombosis and Haemostasis, 20(3), 705-715. https://doi.org/10.1111/jth.15595
    • Post, D. S., van der Veer, A., Schijns, O. E. M. G., Klinkenberg, S., Rijkers, K., Wagner, G. L., van Kranen-Mastenbroek, V. H. J. M., Willems, P. C. P. H., Verhezen, P. W. M., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., & Henskens, Y. M. C. (2022). Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study. PLOS ONE, 17(2), Article e0264351. https://doi.org/10.1371/journal.pone.0264351
    • Hegenbarth, J.-C., Lezzoche, G., De Windt, L. J., & Stoll, M. (2022). Perspectives on Bulk-Tissue RNA Sequencing and Single-Cell RNA Sequencing for Cardiac Transcriptomics. Frontiers in Molecular Medicine, 2, Article 839338. https://doi.org/10.3389/fmmed.2022.839338
    • Hrdinova, J., Fernández, D. I., Ercig, B., Tullemans, B. M. E., Suylen, D. P. L., Agten, S. M., Jurk, K., Hackeng, T. M., Vanhoorelbeke, K., Voorberg, J., Reutelingsperger, C. P. M., Wichapong, K., Heemskerk, J. W. M., & Nicolaes, G. A. F. (2022). Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear. International journal of molecular sciences, 23(4), Article 2046. https://doi.org/10.3390/ijms23042046
    • Hemmers, C., Schulte, C., Wollenhaupt, J., Wong, D. W. L., Harlacher, E., Orth-Alampour, S., Klinkhammer, B. M., Schirmer, S. H., Böhm, M., Marx, N., Speer, T., Boor, P., Jankowski, J., & Noels, H. (2022). Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis. Biomedicines, 10(2), Article 420. https://doi.org/10.3390/biomedicines10020420
    • Linkens, A. M. A., Houben, A. J. H. M., Kroon, A. A., Schram, M. T., Berendschot, T. T. J. M., Webers, C. A. B., van Greevenbroek, M., Henry, R. M. A., de Galan, B., Stehouwer, C. D. A., Eussen, S. J. M. P., & Schalkwijk, C. G. (2022). Habitual intake of dietary advanced glycation end products is not associated with generalized microvascular function-the Maastricht Study. American Journal of Clinical Nutrition, 115(2), 444-455. https://doi.org/10.1093/ajcn/nqab302
    • De With, R. R., Artola Arita, V., Nguyen, B.-O., Linz, D., Ten Cate, H., Spronk, H., Schotten, U., van Zonneveld, A. J., Erküner, Ö., Bayón, M. A., Schmidt, A. S., Luermans, J. G. L. M., Crijns, H. J. G. M., Van Gelder, I. C., & Rienstra, M. (2022). Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies. EP Europace, 24(2), 193-201. https://doi.org/10.1093/europace/euab179
    • Soppert, J., Frisch, J., Wirth, J., Hemmers, C., Boor, P., Kramann, R., Vondenhoff, S., Moellmann, J., Lehrke, M., Hohl, M., van der Vorst, E. P. C., Werner, C., Speer, T., Maack, C., Marx, N., Jankowski, J., Roma, L. P., & Noels, H. (2022). A systematic review and meta-analysis of murine models of uremic cardiomyopathy. Kidney International, 101(2), 256-273. https://doi.org/10.1016/j.kint.2021.10.025
    • Grabowski, K., Herlan, L., Witten, A., Qadri, F., Eisenreich, A., Lindner, D., Schadlich, M., Schulz, A., Subrova, J., Mhatre, K. N., Primessnig, U., Plehm, R., van Linthout, S., Escher, F., Bader, M., Stoll, M., Westermann, D., Heinzel, F. R., & Kreutz, R. (2022). Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension. Hypertension Research, 45(2), 292-307. https://doi.org/10.1038/s41440-021-00826-8
    • Tavenier, A. H., Claassens, D. M. F., Hermanides, R. S., Vos, G. J. A., Bergmeijer, T. O., Kelder, J. C., Deneer, V. H. M., Hof, A. W. J. V. ., & Ten Berg, J. M. (2022). Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y(12) inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial. Catheterization and Cardiovascular interventions, 99(3), 676-685. https://doi.org/10.1002/ccd.29861
    • Mestrum, S. G. C., Cremers, E. M. P., de Wit, N. C. J., Drent, R. J. M., Ramaekers, F. C. S., Hopman, A. H. N., & Leers, M. P. G. (2022). Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes. Leukemia Research, 113, Article 106789. https://doi.org/10.1016/j.leukres.2022.106789
    • Maag, A., van Rein, N., Schuijt, T. J., Kopatz, W. F., Kruijswijk, D., Thomassen, S., Hackeng, T. M., Camire, R. M., van der Poll, T., Meijers, J. C. M., Bos, M. H. A., & van't Veer, C. (2022). Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa. Journal of Thrombosis and Haemostasis, 20(2), 328-338. https://doi.org/10.1111/jth.15589
    • Brouns, S. L. N., Tullemans, B. M. E., Bulato, C., Perrella, G., Campello, E., Spiezia, L., van Geffen, J. P., Kuijpers, M. J. E., van Oerle, R., Spronk, H. M. H., van der Meijden, P. E. J., Simioni, P., & Heemskerk, J. W. M. (2022). Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow. Research and practice in thrombosis and haemostasis, 6(2), Article e12678. https://doi.org/10.1002/rth2.12678
    • Boswijk, E., de Ligt, M., Habets, M. F. J., Mingels, A. M. A., van Marken Lichtenbelt, W. D., Mottaghy, F. M., Schrauwen, P., Wildberger, J. E., & Bucerius, J. (2022). Resveratrol treatment does not reduce arterial inflammation in males at risk of type 2 diabetes: a randomized crossover trial. Nuklearmedizin, 61(01), 33-41. https://doi.org/10.1055/a-1585-7215
    • Andreotti, F., Eikelboom, J., O'Donoghue, M., & ten Berg, J. (2022). New EHJ Team on Thrombosis. European Heart Journal, 43(3), 179-180. https://doi.org/10.1093/eurheartj/ehab732
    • Fernandez, D. I., Provenzale, I., Cheung, H. Y. F., van Groningen, J., Tullemans, B. M. E., Veninga, A., Dunster, J. L., Honarnejad, S., van den Hurk, H., Kuijpers, M. J. E., & Heemskerk, J. W. M. (2022). Ultra-high-throughput Ca2+ assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation. iScience, 25(1), Article 103718. https://doi.org/10.1016/j.isci.2021.103718
    • Spaetgens, B., Nagy, M., & ten Cate, H. (2022). Antiplatelet Therapy in Patients With COVID-19-More Is Less?JAMA-Journal of the American Medical Association, 327(3), 223-224. https://doi.org/10.1001/jama.2021.23866
    • Heuts, S., Denessen, E. J. S., Daemen, J. H. T., Vroemen, W. H. M., Sels, J. W., Segers, P., Bekers, O., Hof, A. W. J. V., Maessen, J. G., van der Horst, I. C. C., & Mingels, A. M. A. (2022). Meta-Analysis Evaluating High-Sensitivity Cardiac Troponin T Kinetics after Coronary Artery Bypass Grafting in Relation to the Current Definitions of Myocardial Infarction. American Journal of Cardiology, 163, 25-31. https://doi.org/10.1016/j.amjcard.2021.09.049
    • Meijs, D. A. M., van Bussel, B. C. T., Stessel, B., Mehagnoul-Schipper, J., Hana, A., Scheeren, C. I. E., Peters, S. A. E., van Mook, W. N. K. A., van der Horst, I. C. C., Marx, G., Mesotten, D., Ghossein-Doha, C., CoDaP Investigators, Heijnen, N. F. L., Raafs, A., van Kuijk, S. M. J., Smits, L. J. M., Janssen, E. B. N. J., Mulder, M. M. G., ... Florack, M. C. D. M. (2022). Better COVID-19 Intensive Care Unit survival in females, independent of age, disease severity, comorbidities, and treatment. Scientific Reports, 12(1), Article 734. https://doi.org/10.1038/s41598-021-04531-x
    • Dongelmans, D. A., Termorshuizen, F., Brinkman, S., Bakhshi-Raiez, F., Arbous, M. S., de Lange, D. W., van Bussel, B. C. T., de Keizer, N. F., & Dutch COVID-19 Research Consortium (2022). Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. Annals of Intensive Care, 12(1), Article 5. https://doi.org/10.1186/s13613-021-00978-3
    • Simons, C. C. J. M., Schouten, L. J., Godschalk, R. W. L., Van Schooten, F. J., Stoll, M., Van Steen, K., van den Brandt, P. A., & Weijenberg, M. P. (2022). Polymorphisms in the mTOR-PI3K-Akt pathway, energy balance-related exposures and colorectal cancer risk in the Netherlands Cohort Study. Biodata Mining, 15(1), Article 2. https://doi.org/10.1186/s13040-021-00286-3
    • Harlacher, E., Wollenhaupt, J., Baaten, C. C. F. M. J., & Noels, H. (2022). Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review. International journal of molecular sciences, 23(1), Article 531. https://doi.org/10.3390/ijms23010531
    • Lip, G. Y. H., Rigby, A., & Weber, C. (2022). A Rollercoaster Plunge into 2022. Thrombosis and Haemostasis, 122(1), 1-4. https://doi.org/10.1055/s-0041-1741073
    • Kaczor, D. M., Kramann, R., Hackeng, T. M., Schurgers, L. J., & Koenen, R. R. (2022). Differential Effects of Platelet Factor 4 (CXCL4) and Its Non-Allelic Variant (CXCL4L1) on Cultured Human Vascular Smooth Muscle Cells. International Journal of Molecular Sciences, 23(2), Article 580. https://doi.org/10.3390/ijms23020580
    • Willems, L. H., Nagy, M., Ten Cate, H., Spronk, H. M. H., Groh, L. A., Leentjens, J., Janssen, N. A. F., Netea, M. G., Thijssen, D. H. J., Hannink, G., van Petersen, A. S., & Warle, M. C. (2022). Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thrombosis Research, 209, 106-114. https://doi.org/10.1016/j.thromres.2021.11.027
    • Weber, C., Rigby, A., & Lip, G. Y. H. (2022). Thrombosis and Haemostasis 2021 Editors' Choice Papers. Thrombosis and Haemostasis, 122(01), 163-170. https://doi.org/10.1055/s-0041-1741072